Stratos Wealth Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $351K | Sell |
1,912
-13
| -0.7% | -$2.4K | ﹤0.01% | 1237 |
|
|
2025
Q4 | $339K | Buy |
1,925
+115
| +6% | +$18.8K | ﹤0.01% | 1218 |
|
|
2025
Q3 | $254K | Sell |
1,810
-86
| -5% | -$11.6K | ﹤0.01% | 1338 |
|
|
2025
Q2 | $238K | Sell |
1,896
-340
| -15% | -$42.4K | ﹤0.01% | 1246 |
|
|
2025
Q1 | $306K | Sell |
2,236
-460
| -17% | -$65.8K | ﹤0.01% | 1089 |
|
|
2024
Q4 | $412K | Sell |
2,696
-500
| -16% | -$84.3K | 0.01% | 1016 |
|
|
2024
Q3 | $620K | Sell |
3,196
-299
| -9% | -$62.6K | 0.01% | 858 |
|
|
2024
Q2 | $810K | Sell |
3,495
-29
| -0.8% | -$6.3K | 0.01% | 723 |
|
|
2024
Q1 | $760K | Sell |
3,524
-499
| -12% | -$117K | 0.01% | 748 |
|
|
2023
Q4 | $1.04M | Sell |
4,023
-9
| -0.2% | -$2.21K | 0.02% | 619 |
|
|
2023
Q3 | $1.04M | Buy |
4,032
+42
| +1% | +$11.2K | 0.02% | 563 |
|
|
2023
Q2 | $1.14M | Sell |
3,990
-20
| -0.5% | -$5.95K | 0.03% | 498 |
|
|
2023
Q1 | $1.11M | Sell |
4,010
-653
| -14% | -$181K | 0.03% | 451 |
|
|
2022
Q4 | $1.29M | Sell |
4,663
-76
| -2% | -$21.5K | 0.03% | 443 |
|
|
2022
Q3 | $1.26M | Sell |
4,739
-85
| -2% | -$18.1K | 0.04% | 419 |
|
|
2022
Q2 | $984K | Buy |
4,824
+1,358
| +39% | +$278K | 0.02% | 521 |
|
|
2022
Q1 | $730K | Sell |
3,466
-355
| -9% | -$77.2K | 0.02% | 657 |
|
|
2021
Q4 | $917K | Sell |
3,821
-288
| -7% | -$74.1K | 0.02% | 582 |
|
|
2021
Q3 | $1.16M | Sell |
4,109
-107
| -3% | -$35.1K | 0.03% | 474 |
|
|
2021
Q2 | $1.46M | Buy |
4,216
+195
| +5% | +$59.1K | 0.04% | 433 |
|
|
2021
Q1 | $1.13M | Sell |
4,021
-284
| -7% | -$76.6K | 0.03% | 467 |
|
|
2020
Q4 | $1.05M | Sell |
4,305
-504
| -10% | -$130K | 0.03% | 431 |
|
|
2020
Q3 | $1.36M | Sell |
4,809
-895
| -16% | -$250K | 0.04% | 322 |
|
|
2020
Q2 | $1.53M | Sell |
5,704
-1,154
| -17% | -$347K | 0.05% | 300 |
|
|
2020
Q1 | $2.17M | Sell |
6,858
-497
| -7% | -$151K | 0.1% | 206 |
|
|
2019
Q4 | $2.18M | Sell |
7,355
-189
| -3% | -$52.4K | 0.09% | 229 |
|
|
2019
Q3 | $1.76M | Sell |
7,544
-22
| -0.3% | -$5.12K | 0.08% | 251 |
|
|
2019
Q2 | $1.77M | Sell |
7,566
-97
| -1% | -$22.4K | 0.08% | 246 |
|
|
2019
Q1 | $1.81M | Sell |
7,663
-411
| -5% | -$129K | 0.08% | 249 |
|
|
2018
Q4 | $2.43M | Sell |
8,074
-334
| -4% | -$107K | 0.13% | 179 |
|
|
2018
Q3 | $2.97M | Sell |
8,408
-115
| -1% | -$39.6K | 0.13% | 162 |
|
|
2018
Q2 | $2.47M | Sell |
8,523
-428
| -5% | -$120K | 0.11% | 203 |
|
|
2018
Q1 | $2.45M | Sell |
8,951
-89
| -1% | -$27.6K | 0.1% | 209 |
|
|
2017
Q4 | $2.88M | Buy |
9,040
+163
| +2% | +$52.3K | 0.13% | 164 |
|
|
2017
Q3 | $2.78M | Sell |
8,877
-209
| -2% | -$61.9K | 0.13% | 166 |
|
|
2017
Q2 | $2.47M | Buy |
9,086
+518
| +6% | +$137K | 0.13% | 163 |
|
|
2017
Q1 | $2.34M | Buy |
8,568
+657
| +8% | +$186K | 0.13% | 158 |
|
|
2016
Q4 | $2.24M | Sell |
7,911
-188
| -2% | -$55.7K | 0.14% | 148 |
|
|
2016
Q3 | $2.54M | Buy |
8,099
+378
| +5% | +$112K | 0.17% | 121 |
|
|
2016
Q2 | $1.87M | Buy |
7,721
+546
| +8% | +$144K | 0.14% | 150 |
|
|
2016
Q1 | $1.87M | Buy |
7,175
+334
| +5% | +$88.2K | 0.16% | 117 |
|
|
2015
Q4 | $2.1M | Buy |
6,841
+5,892
| +621% | +$1.69M | 0.17% | 104 |
|
|
2015
Q3 | $277K | Sell |
949
-145
| -13% | -$47.9K | 0.03% | 396 |
|
|
2015
Q2 | $442K | Sell |
1,094
-239
| -18% | -$95.9K | 0.06% | 277 |
|
|
2015
Q1 | $562K | Buy |
1,333
+358
| +37% | +$141K | 0.07% | 263 |
|
|
2014
Q4 | $331K | Sell |
975
-70
| -7% | -$22.6K | 0.06% | 330 |
|
|
2014
Q3 | $346K | Buy |
1,045
+241
| +30% | +$79.5K | 0.08% | 208 |
|
|
2014
Q2 | $254K | Buy |
+804
| New | +$242K | 0.08% | 249 |
|
Other funds holding BIIB
VCM
VPM
Stratos Wealth Partners's BIIB Position: Q1 2026 in Review
Stratos Wealth Partners reduced its Biogen (BIIB) stake by 0.68% in Q1 2026, selling an estimated $2.4K and leaving 1,912 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.
Stratos Wealth Partners first reported a position in BIIB in Q2 2014 and has held it in 48 quarters since. The position peaked at $2.97M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Stratos Wealth Partners held 1,912 shares of Biogen worth $351K as of Q1 2026.
- Stratos Wealth Partners sold 13 Biogen shares in Q1 2026, an estimated $2.4K.
- Biogen made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #1237 holding.
- Stratos Wealth Partners first reported a position in Biogen in Q2 2014 and has held it in 48 quarters since.
- Stratos Wealth Partners's Biogen position peaked at $2.97M in Q3 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.